Specific effect of a dopamine partial agonist on counterfactual learning: evidence from Gilles de la Tourette syndrome

The dopamine partial agonist aripiprazole is increasingly used to treat pathologies for which other antipsychotics are indicated because it displays fewer side effects, such as sedation and depression-like symptoms, than other dopamine receptor antagonists. Previously, we showed that aripiprazole ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvador, Alexandre, Worbe, Yulia, Delorme, Cécile, Coricelli, Giorgio, Gaillard, Raphaël, Robbins, Trevor W., Hartmann, Andreas, Palminteri, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524760/
https://www.ncbi.nlm.nih.gov/pubmed/28740149
http://dx.doi.org/10.1038/s41598-017-06547-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524760/
https://www.ncbi.nlm.nih.gov/pubmed/28740149
http://dx.doi.org/10.1038/s41598-017-06547-8

Ejemplares similares